The process typically starts with the selection of appropriate cell lines that represent different types of cancer. These cells are then exposed to a library of compounds at various concentrations. Researchers use assays to measure cell viability, proliferation, apoptosis, and other cellular responses. Techniques such as high-throughput screening (HTS) and high-content screening (HCS) are commonly employed to handle large volumes of compounds efficiently.
